{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:19:18Z","timestamp":1788477558708,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shanxi Provincial Natural Fund Project","award":["202203021211239"],"award-info":[{"award-number":["202203021211239"]}]},{"name":"Shanxi Provincial Natural Fund Project","award":["202303021211126"],"award-info":[{"award-number":["202303021211126"]}]},{"name":"Shanxi Province Higher Education \"Billion Project\" Science and Technology Guidance Project","award":["BYJL045"],"award-info":[{"award-number":["BYJL045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12602-025-10763-4","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:33:49Z","timestamp":1761629629000},"page":"4906-4924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gut Microbiota Dysbiosis and LPS\/NLRP3\/GSDMD Pyroptosis Drive Hepatic Fibrosis: Therapeutic Potential of a Synbiotic Intervention"],"prefix":"10.1007","volume":"18","author":[{"given":"Yuxin","family":"Che","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhuan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzhi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"3","key":"10763_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D (2021) Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 18(3):151\u2013166","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10763_CR2","doi-asserted-by":"publisher","unstructured":"Schuppan D, Ashfaq-Khan M, Yang AT, Kim YO (2018) Liver fibrosis: direct antifibrotic agents and targeted therapies. Matrix Biol 68\u201369:435\u2013451.https:\/\/doi.org\/10.1016\/j.matbio.2018.04.006","DOI":"10.1016\/j.matbio.2018.04.006"},{"issue":"2","key":"10763_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41569-020-0433-5","volume":"18","author":"C Matyas","year":"2021","unstructured":"Matyas C, Hasko G, Liaudet L, Trojnar E, Pacher P (2021) Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. Nat Rev Cardiol 18(2):117\u2013135","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"10763_CR4","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.14336\/AD.2019.0116","volume":"10","author":"J Wu","year":"2019","unstructured":"Wu J, Lin S, Wan B, Velani B, Zhu Y (2019) Pyroptosis in liver disease: new insights into disease mechanisms. Aging Dis 10(5):1094\u20131108","journal-title":"Aging Dis"},{"key":"10763_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00758","volume":"9","author":"J Luan","year":"2018","unstructured":"Luan J, Zhang X, Wang S, Li Y, Fan J, Chen W, Zai W, Wang S, Wang Y, Chen M, Meng G, Ju D (2018) NOD-like receptor protein 3 inflammasome-dependent IL-1beta accelerated ConA-induced hepatitis. Front Immunol 9:758","journal-title":"Front Immunol"},{"issue":"1","key":"10763_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","volume":"74","author":"S Gaul","year":"2021","unstructured":"Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA, Wree A, Damm G, Seehofer D, Calvente CJ, Povero D, Kisseleva T, Eguchi A, McGeough MD, Hoffman HM, Pelegrin P, Laufs U, Feldstein AE (2021) Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol 74(1):156\u2013167","journal-title":"J Hepatol"},{"key":"10763_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00018","volume":"10","author":"S Wan","year":"2020","unstructured":"Wan S, Nie Y, Zhang Y, Huang C, Zhu X (2020) Gut microbial dysbiosis is associated with profibrotic factors in liver fibrosis mice. Front Cell Infect Microbiol 10:18","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"10763_CR8","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3748\/wjg.v30.i11.1556","volume":"30","author":"YC Hu","year":"2024","unstructured":"Hu YC, Ding XC, Liu HJ, Ma WL, Feng XY, Ma LN (2024) Effects of Lactobacillus paracasei N1115 on gut microbial imbalance and liver function in patients with hepatitis B-related cirrhosis. World J Gastroenterol 30(11):1556\u20131571","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10763_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M (2020) The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol 72(3):558\u2013577","journal-title":"J Hepatol"},{"issue":"8","key":"10763_CR10","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1136\/gutjnl-2018-316670","volume":"68","author":"L Liao","year":"2019","unstructured":"Liao L, Schneider KM, Galvez EJC, Frissen M, Marschall HU, Su H, Hatting M, Wahlstrom A, Haybaeck J, Puchas P, Mohs A, Peng J, Bergheim I, Nier A, Hennings J, Reissing J, Zimmermann HW, Longerich T, Strowig T, Liedtke C, Cubero FJ, Trautwein C (2019) Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis. Gut 68(8):1477\u20131492","journal-title":"Gut"},{"issue":"1","key":"10763_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31312-5","volume":"13","author":"KM Schneider","year":"2022","unstructured":"Schneider KM, Mohs A, Gui W, Galvez EJC, Candels LS, Hoenicke L, Muthukumarasamy U, Holland CH, Elfers C, Kilic K, Schneider CV, Schierwagen R, Strnad P, Wirtz TH, Marschall HU, Latz E, Lelouvier B, Saez-Rodriguez J, de Vos W, Strowig T, Trebicka J, Trautwein C (2022) Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment. Nat Commun 13(1):3964","journal-title":"Nat Commun"},{"issue":"4","key":"10763_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jhin.2017.04.007","volume":"96","author":"Y Kang","year":"2017","unstructured":"Kang Y, Cai Y (2017) Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy. J Hosp Infect 96(4):342\u2013348","journal-title":"J Hosp Infect"},{"issue":"7","key":"10763_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202200428","volume":"67","author":"Q Liu","year":"2023","unstructured":"Liu Q, Yang H, Kang X, Tian H, Kang Y, Li L, Yang X, Liu H, Ren P, Kuang X, Tong M, Fan W (2023) A synbiotic ameliorates Con A-induced autoimmune hepatitis in mice through modulation of gut microbiota and immune imbalance. Mol Nutr Food Res 67(7):e2200428","journal-title":"Mol Nutr Food Res"},{"key":"10763_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2021.108863","volume":"98","author":"Q Liu","year":"2021","unstructured":"Liu Q, Tian H, Kang Y, Tian Y, Li L, Kang X, Yang H, Wang Y, Tian J, Zhang F, Tong M, Cai H, Fan W (2021) Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability. J Nutr Biochem 98:108863","journal-title":"J Nutr Biochem"},{"issue":"1","key":"10763_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12602-022-10005-x","volume":"15","author":"H Liu","year":"2023","unstructured":"Liu H, Kang X, Yang X, Yang H, Kuang X, Ren P, Yan H, Shen X, Kang Y, Li L, Wang X, Guo L, Tong M, Fan W (2023) Compound probiotic ameliorates acute alcoholic liver disease in mice by modulating gut microbiota and maintaining intestinal barrier. Probiotics Antimicrob Proteins 15(1):185\u2013201","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10763_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106020","volume":"175","author":"Y Kang","year":"2022","unstructured":"Kang Y, Kang X, Yang H, Liu H, Yang X, Liu Q, Tian H, Xue Y, Ren P, Kuang X, Cai Y, Tong M, Li L, Fan W (2022) Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability. Pharmacol Res 175:106020","journal-title":"Pharmacol Res"},{"issue":"2","key":"10763_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01127-22","volume":"8","author":"Y Kang","year":"2023","unstructured":"Kang Y, Kuang X, Yan H, Ren P, Yang X, Liu H, Liu Q, Yang H, Kang X, Shen X, Tong M, Li L, Wang X, Guo L, Ma J, Zhang F, Fan W (2023) A novel synbiotic alleviates autoimmune hepatitis by modulating the gut microbiota-liver axis and inhibiting the hepatic TLR4\/NF-kappaB\/NLRP3 signaling pathway. mSystems 8(2):e0112722","journal-title":"mSystems"},{"issue":"1","key":"10763_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12866-020-01953-x","volume":"20","author":"R Hu","year":"2020","unstructured":"Hu R, Lin H, Li J, Zhao Y, Wang M, Sun X, Min Y, Gao Y, Yang M (2020) Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages. BMC Microbiol 20(1):268. https:\/\/doi.org\/10.1186\/s12866-020-01953-x","journal-title":"BMC Microbiol"},{"issue":"3","key":"10763_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1248\/bpb.b21-00924","volume":"45","author":"M Morishita","year":"2022","unstructured":"Morishita M, Sagayama R, Yamawaki Y, Yamaguchi M, Katsumi H, Yamamoto A (2022) Activation of host immune cells by probiotic-derived extracellular vesicles via TLR2-mediated signaling pathways. Biol Pharm Bull 45(3):354\u2013359. https:\/\/doi.org\/10.1248\/bpb.b21-00924","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"10763_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/mi.2016.57","volume":"10","author":"Y Wang","year":"2017","unstructured":"Wang Y, Liu L, Moore DJ, Shen X, Peek RM, Acra SA, Li H, Ren X, Polk DB, Yan F (2017) An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells. Mucosal Immunol 10(2):373\u2013384","journal-title":"Mucosal Immunol"},{"key":"10763_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911162","author":"J Zheng","year":"2022","unstructured":"Zheng J, Ahmad AA, Yang Y, Liang Z, Shen W, Feng M, Shen J, Lan X, Ding X (2022) Lactobacillus rhamnosus CY12 enhances intestinal barrier function by regulating tight junction protein expression, oxidative stress, and inflammation response in lipopolysaccharide-induced Caco-2 cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms231911162","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10763_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","volume":"10","author":"C Gan","year":"2025","unstructured":"Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z, Guo Y, Wang H, Dong E, Xiao J (2025) Liver diseases: epidemiology, causes, trends and predictions. Signal Transduct Target Ther 10(1):33. https:\/\/doi.org\/10.1038\/s41392-024-02072-z","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"10763_CR23","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.4254\/wjh.v13.i11.1688","volume":"13","author":"MA Kalas","year":"2021","unstructured":"Kalas MA, Chavez L, Leon M, Taweesedt PT, Surani S (2021) Abnormal liver enzymes: a review for clinicians. World J Hepatol 13(11):1688\u20131698","journal-title":"World J Hepatol"},{"key":"10763_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116982","volume":"239","author":"MM Salah","year":"2019","unstructured":"Salah MM, Ashour AA, Abdelghany TM, Abdel-Aziz AH, Salama SA (2019) Pirfenidone alleviates concanavalin A-induced liver fibrosis in mice. Life Sci 239:116982","journal-title":"Life Sci"},{"issue":"1","key":"10763_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03356-y","volume":"24","author":"Y Pan","year":"2024","unstructured":"Pan Y, Yang Y, Wu J, Zhou H, Yang C (2024) Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. BMC Gastroenterol 24(1):283","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"10763_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F (2023) Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol 20(10):633\u2013646","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10763_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s43556-025-00249-8","volume":"6","author":"Y Li","year":"2025","unstructured":"Li Y, Guo B (2025) GSDMD-mediated pyroptosis: molecular mechanisms, diseases and therapeutic targets. Mol Biomed 6(1):11. https:\/\/doi.org\/10.1186\/s43556-025-00249-8","journal-title":"Mol Biomed"},{"issue":"1","key":"10763_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1972746","volume":"13","author":"Y Nie","year":"2021","unstructured":"Nie Y, Liu Q, Zhang W, Wan Y, Huang C, Zhu X (2021) Ursolic acid reverses liver fibrosis by inhibiting NOX4\/NLRP3 inflammasome pathways and bacterial dysbiosis. Gut Microbes 13(1):1972746","journal-title":"Gut Microbes"},{"issue":"11","key":"10763_CR29","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg H, Adolph TE, Trauner M (2022) Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab 34(11):1700\u20131718","journal-title":"Cell Metab"},{"issue":"Suppl 1","key":"10763_CR30","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/j.jhep.2020.11.013","volume":"75 Suppl 1","author":"J Trebicka","year":"2021","unstructured":"Trebicka J, Macnaughtan J, Schnabl B, Shawcross DL, Bajaj JS (2021) The microbiota in cirrhosis and its role in hepatic decompensation. J Hepatol 75 Suppl 1(Suppl 1):S67\u2013S81. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.013","journal-title":"J Hepatol"},{"issue":"1","key":"10763_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.12938\/bmfh.2020-046","volume":"40","author":"COM Jasirwan","year":"2021","unstructured":"Jasirwan COM, Muradi A, Hasan I, Simadibrata M, Rinaldi I (2021) Correlation of gut Firmicutes\/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease. Biosci Microbiota Food Health 40(1):50\u201358","journal-title":"Biosci Microbiota Food Health"},{"issue":"5","key":"10763_CR32","doi-asserted-by":"publisher","first-page":"e0171722","DOI":"10.1128\/spectrum.01717-22","volume":"10","author":"K Wang","year":"2022","unstructured":"Wang K, Wu W, Jiang X, Xia J, Lv L, Li S, Zhuge A, Wu Z, Wang Q, Wang S, Li L (2022) Multi-omics analysis reveals the protection of gasdermin D in concanavalin a-induced autoimmune hepatitis. Microbiol Spectr 10(5):e0171722. https:\/\/doi.org\/10.1128\/spectrum.01717-22","journal-title":"Microbiol Spectr"},{"key":"10763_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116598","volume":"55","author":"L Yang","year":"2022","unstructured":"Yang L, Yu S, Yang Y, Wu H, Zhang X, Lei Y, Lei Z (2022) Berberine improves liver injury induced glucose and lipid metabolic disorders via alleviating ER stress of hepatocytes and modulating gut microbiota in mice. Bioorg Med Chem 55:116598","journal-title":"Bioorg Med Chem"},{"key":"10763_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1152987","volume":"13","author":"F Yan","year":"2023","unstructured":"Yan F, Zhang Q, Shi K, Zhang Y, Zhu B, Bi Y, Wang X (2023) Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response. Front Cell Infect Microbiol 13:1152987","journal-title":"Front Cell Infect Microbiol"},{"key":"10763_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1347120","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Xu X, Tao S, Su Y, Wen L, Wang D, Liu J, Feng Q (2024) Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl(4)-induced hepatic fibrosis. Front Pharmacol 15:1347120","journal-title":"Front Pharmacol"},{"key":"10763_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312687","author":"L Maccioni","year":"2021","unstructured":"Maccioni L, Leclercq IA, Schnabl B, Starkel P (2021) Host factors in dysregulation of the gut barrier function during alcohol-associated liver disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222312687","journal-title":"Int J Mol Sci"},{"key":"10763_CR37","doi-asserted-by":"publisher","unstructured":"Di Tommaso N, Gasbarrini A, Ponziani FR (2021) Intestinal barrier in human health and disease. Int J Environ Res Public Health 18(23). https:\/\/doi.org\/10.3390\/ijerph182312836","DOI":"10.3390\/ijerph182312836"},{"key":"10763_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093211","author":"HY Li","year":"2021","unstructured":"Li HY, Zhou DD, Gan RY, Huang SY, Zhao CN, Shang A, Xu XY, Li HB (2021) Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: a narrative review. Nutrients. https:\/\/doi.org\/10.3390\/nu13093211","journal-title":"Nutrients"},{"issue":"1","key":"10763_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/ibd\/izae232","volume":"31","author":"P Arumugam","year":"2025","unstructured":"Arumugam P, Saha K, Nighot P (2025) Intestinal epithelial tight junction barrier regulation by novel pathways. Inflamm Bowel Dis 31(1):259\u2013271","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10763_CR40","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12072-010-9219-x","volume":"4","author":"JB Soares","year":"2010","unstructured":"Soares JB, Pimentel-Nunes P, Roncon-Albuquerque R, Leite-Moreira A (2010) The role of lipopolysaccharide\/toll-like receptor 4 signaling in chronic liver diseases. Hepatol Int 4(4):659\u2013672","journal-title":"Hepatol Int"},{"key":"10763_CR41","doi-asserted-by":"publisher","unstructured":"Maslennikov R, Poluektova E, Zolnikova O, Sedova A, Kurbatova A, Shulpekova Y, Dzhakhaya N, Kardasheva S, Nadinskaia M, Bueverova E, Nechaev V, Karchevskaya A, Ivashkin V (2023) Gut microbiota and bacterial translocation in the pathogenesis of liver fibrosis. Int J Mol Sci 24 (22). https:\/\/doi.org\/10.3390\/ijms242216502","DOI":"10.3390\/ijms242216502"},{"issue":"8","key":"10763_CR42","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","volume":"76","author":"Z Safari","year":"2019","unstructured":"Safari Z, Gerard P (2019) The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci 76(8):1541\u20131558. https:\/\/doi.org\/10.1007\/s00018-019-03011-w","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10763_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010199","volume":"22","author":"NY Lee","year":"2020","unstructured":"Lee NY, Suk KT (2020) The role of the gut microbiome in liver cirrhosis treatment. Int J Mol Sci 22(1):199","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10763_CR44","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/jn\/nxy088","volume":"148","author":"F Bakhshimoghaddam","year":"2018","unstructured":"Bakhshimoghaddam F, Shateri K, Sina M, Hashemian M, Alizadeh M (2018) Daily consumption of synbiotic yogurt decreases liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial. J Nutr 148(8):1276\u20131284","journal-title":"J Nutr"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10763-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10763-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10763-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:59:10Z","timestamp":1778749150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10763-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10763"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10763-4","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}